Mesenchymal stromal cell‐based therapies reduce obesity and metabolic syndromes induced by a high‐fat diet

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.trsl.2016.11.003PMID 27908750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary luteolin activates browning and thermogenesis in mice through an AMPK/PGC1α pathway-mediated mechanism

  2016cited by this paper
• IEX-1 deficiency induces browning of white adipose tissue and resists diet-induced obesity

  2016cited by this paper
• Preview : Published ahead of advance online publication The intake of high fat diets induces the acquisition of brown adipocyte gene expression features in white adipose tissue

  2015cited by this paper
• Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.

  2015cited by this paper
• Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice

  2015cited by this paper
• The intake of high-fat diets induces the acquisition of brown adipocyte gene expression features in white adipose tissue

  2015cited by this paper
• Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat.

  2015cited by this paper
• Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.

  2015cited by this paper
• The Therapeutic Potential of Brown Adipocytes in Humans

  2015cited by this paper
• The brown fat secretome: metabolic functions beyond thermogenesis.

  2015cited by this paper
• Niche-Dependent Regulations of Metabolic Balance in High-Fat Diet–Induced Diabetic Mice by Mesenchymal Stromal Cells

  2014cited by this paper
• Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Exosomes Derived from Mesenchymal Stem Cells

  2014cited by this paper
• Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines

  2013cited by this paper
• Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings

  2013cited by this paper
• Brown adipose tissue regulates glucose homeostasis and insulin sensitivity.

  2013cited by this paper
• Role of leptin and adiponectin in insulin resistance.

  2013cited by this paper
• Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long‐Term Engraftment and No Ectopic Tissue Formation

  2012cited by this paper
• Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity

  2012cited by this paper
• Update on Pparγ and Nonalcoholic Fatty Liver Disease

  2012cited by this paper
• Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.

  2011cited by this paper
• Inflammatory links between obesity and metabolic disease.

  2011cited by this paper
• Brown adipose tissue activity controls triglyceride clearance

  2011cited by this paper
• The Role of PPARα Activation in Liver and Muscle

  2010cited by this paper
• The role of peroxisome proliferator‐activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus

  2010cited by this paper
• Hyperleptinemia Is Required for the Development of Leptin Resistance

  2010cited by this paper
• Mesenchymal stem cells as therapeutics.

  2010cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010cited by this paper
• Human Multipotent Adipose‐Derived Stem Cells Differentiate into Functional Brown Adipocytes

  2009cited by this paper
• Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver disease

  2009cited by this paper
• Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

  2009cited by this paper
• Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.

  2008cited by this paper
• White adipose tissue as endocrine organ and its role in obesity.

  2008cited by this paper
• PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism

  2007cited by this paper
• The adipocyte as an active participant in energy balance and metabolism.

  2007cited by this paper
• PPAR gamma and human metabolic disease.

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006cited by this paper
• Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator–Activated Receptor α

  2006cited by this paper
• PPARγ and human metabolic disease

  2006cited by this paper
• Adipokines that link obesity and diabetes to the hypothalamus.

  2006cited by this paper
• Peroxisome Proliferator–Activated Receptor α Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets

  2006cited by this paper
• Cytokines and the pathogenesis of non-alcoholic steatohepatitis

  2005cited by this paper
• Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200

  2005cited by this paper
• Adipose tissue as an endocrine organ.

  2004cited by this paper
• Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells

  2004cited by this paper
• In vitro hepatic differentiation of human mesenchymal stem cells

  2004cited by this paper
• Acute (24 h) activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets.

  2003cited by this paper
• Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells

  2002cited by this paper
• PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells.

  2002cited by this paper
• PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes.

  1998cited by this paper
• In Vivo and in Vitro Evidence for the Involvement of Tumor Necrosis Factor-α in the Induction of Leptin by Lipopolysaccharide.

  1998cited by this paper
• In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide.

  1998cited by this paper
• Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes.

  1997cited by this paper
• Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia

  1997cited by this paper
• Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

  1996cited by this paper
• Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

  1995cited by this paper
• Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action

  1995cited by this paper

• Milking mesenchymal stem cells: Updated protocols for cell lysate, secretome, and exosome extraction, and comparative analysis of their therapeutic potential.

  2025cites this paper
• Integrated strategies from stem cells to exosomes for amelioration of insulin resistance and promoting β-cell regeneration in diabesity.

  2025cites this paper
• Preclinical research in obesity-associated metabolic diseases using in vitro, multicellular, and non-mammalian models

  2025cites this paper
• Palmitate enhances MSC immunomodulation of human macrophages via the ceramide/CCL2 axis in vitro

  2025cites this paper
• Donor-specific response of visceral adipocytes differentiated from human adipose-derived mesenchymal stem cells to branched-chain alpha-keto acid (BCKA) dehydrogenase activation.

  2025cites this paper
• Label‐Free Sorting of Human Mesenchymal Stem Cells Using Insulating Dielectrophoresis

  2025cites this paper
• In vivo brown adipogenic reprogramming induced by a small molecule cocktail.

  2025cites this paper
• A review of adipose-derived mesenchymal stem cells‘ impacts and challenges: metabolic regulation, tumor modulation, immunomodulation, regenerative medicine and genetic engineering therapies

  2025cites this paper
• Transplantation of Exercise-Enhanced Mesenchymal Stem Cells Improves Obesity and Glucose Tolerance via Immune Modulation in Adipose Tissue

  2025cites this paper
• Cell and gene therapeutic approaches in non-alcoholic fatty liver disease.

  2025cites this paper
• Bladder dysfunction in hypoestrogenic rats with metabolic syndrome can be ameliorated after amniotic fluid stem cell treatment

  2025cites this paper
• Unleashing the potential of adipose organoids: A revolutionary approach to combat obesity-related metabolic diseases

  2024influential citation
• Controlled release of hydrogel-encapsulated mesenchymal stem cells-conditioned medium promotes functional liver regeneration after hepatectomy in metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives

  2024cites this paper
• The Effect of Exercise on Mesenchymal Stem Cells and their Application in Obesity Treatment

  2024influential citation
• Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice.

  2024cites this paper
• Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition

  2024cites this paper
• Cell-Free Therapies: The Use of Cell Extracts to Mitigate Irradiation-Injured Salivary Glands

  2023influential citation
• Therapeutic of Mesenchymal Stem Cells in Diabetes

  2023cites this paper
• Single-cell transcriptome analysis reveals the effectiveness of cytokine priming irrespective of heterogeneity in mesenchymal stromal cells.

  2023cites this paper
• Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis

  2023cites this paper
• Comparison of effects of HucMSCs, exosomes, and conditioned medium on NASH

  2023cites this paper
• Dilemma of Epigenetic Changes Causing or Reducing Metabolic Disorders in Offsprings of Obese Mothers

  2023cites this paper
• Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside

  2023cites this paper
• Influence of type 2 diabetes and obesity on adipose mesenchymal stem/stromal cell immunoregulation

  2023cites this paper
• Mesenchymal Stem/Stromal Cells Therapy For Metabolic Syndrome: Potential Clinical Application?

  2023cites this paper
• Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice.

  2023cites this paper
• Gene Therapy Based on Mesenchymal Stem Cells Derived from Adipose Tissue for the Treatment of Obesity and Its Metabolic Complications

  2023influential citation
• Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis

  2023cites this paper
• Current, emerging, and potential therapies for non-alcoholic steatohepatitis

  2023cites this paper
• Immunomodulatory Functions of Adipose Mesenchymal Stromal/Stem Cell Derived From Donors With Type 2 Diabetes and Obesity on CD4 T Cells

  2023cites this paper
• Immunomodulatory Properties of Human Adipose Mesenchymal Stromal/Stem Cell in Type 2 Diabetes Milieu.

  2023cites this paper
• Translating MSC Therapy in the Age of Obesity

  2022cites this paper
• Using adipose‐derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?

  2022influential citation
• Cadherin-11 Influences Differentiation in Human Mesenchymal Stem Cells by Regulating the Extracellular Matrix Via the TGFβ1 Pathway

  2022cites this paper
• Human Mesenchymal Stromal Cells Resolve Lipid Load in High Fat Diet-Induced Non-Alcoholic Steatohepatitis in Mice by Mitochondria Donation

  2022cites this paper
• A long-term anti-inflammation markedly alleviated high-fat diet-induced obesity by repeated administrations of overexpressing IL10 human umbilical cord-derived mesenchymal stromal cells

  2022cites this paper
• Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes

  2022cites this paper
• The evolving view of thermogenic fat and its implications in cancer and metabolic diseases

  2022cites this paper
• HGF secreted by menstrual blood-derived endometrial stem cells ameliorates non-alcoholic fatty liver disease through downregulation of hepatic Rnf186.

  2022cites this paper
• The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice

  2021cites this paper
• Adipose-derived mesenchymal stem cells attenuate dialysis-induced peritoneal fibrosis by modulating macrophage polarization via interleukin-6

  2021cites this paper
• Mesenchymal stromal cell‐mediated immune regulation: A promising remedy in the therapy of type 2 diabetes mellitus

  2021cites this paper
• Adipose-derived stem cells and obesity: The spear and shield relationship.

  2021cites this paper
• The Hepatic Stellate Cells (HSTCs) and Adipose-derived Mesenchymal Stem Cells (ASCs) Axis as a Potential Major Driver of Metabolic Syndrome – Novel Concept and Therapeutic Implications

  2021cites this paper
• Stem Cell Research Tools in Human Metabolic Disorders: An Overview

  2021cites this paper
• Irisin Enhances Angiogenesis of Mesenchymal Stem Cells to Promote Cardiac Function in Myocardial Infarction via PI3k/Akt Activation

  2021cites this paper
• Exendin-4 gene modification and microscaffold encapsulation promote self-persistence and antidiabetic activity of MSCs

  2021cites this paper
• Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells

  2021cites this paper
• Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model

  2021cites this paper
• Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model

  2020cites this paper
• Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH

  2020cites this paper
• Brown Adipose Tissue in Obesity and Diabetes

  2020cites this paper
• Modeling Diet-Induced Metabolic Syndrome in Rodents.

  2020cites this paper
• Cell-Based Medicine and Therapy

  2019cites this paper
• The beneficial effects of brown adipose tissue transplantation.

  2019cites this paper
• Brown and beige fat: From molecules to physiology and pathophysiology.

  2019cites this paper
• Ferulic acid maintains the self-renewal capacity of embryo stem cells and adipose-derived mesenchymal stem cells in high fat diet-induced obese mice.

  2019cites this paper
• IL6 Receptor Facilitates Adipogenesis Differentiation of Human Mesenchymal Stem Cells through Activating P38 Pathway

  2019cites this paper
• Metabolic Syndrome and Skin Diseases

  2019cites this paper
• DMSO_A_214093 1473..1492

  2019cites this paper
• Ectopic brown adipose tissue formation within skeletal muscle after brown adipose progenitor cell transplant augments energy expenditure

  2019cites this paper
• Leptin enhances glycolysis via OPA1-mediated mitochondrial fusion to promote mesenchymal stem cell survival.

  2019cites this paper
• Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration

  2019cites this paper
• Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice

  2019cites this paper
• Stem Cell and Obesity: Current State and Future Perspective.

  2018cites this paper
• Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.

  2018cites this paper
• Obesity related adipokines release in rat adipose derived stem cell cultures influenced by pulsed electromagnetic field.

  2018cites this paper
• Can mesenchymal stem cell lysate reverse aging?

  2018influential citation
• New approaches targeting brown adipose tissue transplantation as a therapy in obesity.

  2018cites this paper
• Leptin: A new therapeutic target for treatment of diabetes mellitus

  2018cites this paper
• Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats

  2018cites this paper
• A homologous stem cell therapy for obesity and its related metabolic disorders.

  2017cites this paper
• Cell source, differentiation, functional stimulation, and potential application of human thermogenic adipocytes in vitro

  2016influential citation
• Cell source, differentiation, functional stimulation, and potential application of human thermogenic adipocytes in vitro

  2016influential citation
• World Journal of Stem Cells

  year unknowncites this paper